Search

everythinglearnresearchcommunity

for

Search:↓

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Mycophenolate mofetil is effective for treating severe lupus nephritis in children.

Corticosteroid injections are the most effective treatment for alopecia areata.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Dupilumab and oral JAK inhibitors are effective for treating alopecia areata with atopic diseases.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

Age-related immune changes significantly affect disease development in other systems.

Stromal cells in melanoma promote tumor growth and spread.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Prednisone has risks for lupus patients, isotretinoin is safe for mental health, transplant patients risk skin cancer, and various treatments are effective for specific skin conditions.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

γδ T cells can prevent and treat alopecia areata, offering a new therapy option.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

Some treatments for inflammatory bowel disease can cause skin problems like rashes and melanoma.

Topical immunotherapy is more effective than dapsone for treating severe alopecia areata.

IL-1 signaling is crucial for hair follicle stem cell growth and wound healing.

More effective treatments are needed for alopecia areata, hidradenitis suppurativa, and vitiligo.

More precise, personalized therapies are needed for autoimmune diseases.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.